Commission Implementing Decision (EU) 2017/2201 of 27 November 2017 authorising t... (32017D2201)
Commission Implementing Decision (EU) 2017/2201 of 27 November 2017 authorising the placing on the market of 2′-fucosyllactose produced with Escherichia coli strain BL21 as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 7662)
- COMMISSION IMPLEMENTING DECISION (EU) 2017/2201
- of 27 November 2017
- authorising the placing on the market of 2′-fucosyllactose produced with
- Escherichia coli
- strain BL21 as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council
- (notified under document C(2017) 7662)
- (Only the German text is authentic)
- Article 1
- Article 2
- Article 3
- ANNEX I
- SPECIFICATIONS OF 2′-FUCOSYLLACTOSE
- Specifications of 2′-fucosyllactose powder
- Specifications of 2′-fucosyllactose liquid concentrate
- ANNEX II
- Authorised uses of 2′-fucosyllactose powder and liquid concentrate
Feedback